Eltrocib 25mg Tablet

About

Eltrocib 25mg Tablet is a selective cyclooxygenase-2 (COX-2) inhibitor, belonging to the class of non-steroidal anti-inflammatory drugs (NSAIDs). It functions by specifically inhibiting the COX-2 enzyme, which is responsible for the synthesis of prostaglandins that mediate pain and inflammation. By targeting COX-2, this medication effectively reduces inflammatory responses and alleviates pain, while minimizing the impact on the COX-1 enzyme, which plays a role in maintaining the integrity of the gastrointestinal lining. This lower dose formulation is suitable for patients requiring milder anti-inflammatory or analgesic effects, or for those who are more sensitive to higher doses, providing a balanced approach to managing chronic pain and inflammatory conditions. It offers a therapeutic option for long-term management with a potentially improved safety profile compared to non-selective NSAIDs.

Uses

• Symptomatic relief of mild to moderate osteoarthritis.
• Management of acute musculoskeletal pain.
• Treatment of primary dysmenorrhea.
• Adjunctive therapy for certain inflammatory conditions.

Directions For Use

Take orally with or without food, as directed by your physician. Do not exceed the prescribed daily dose.

Benefits

• Provides effective pain and inflammation relief.
• Reduced risk of gastrointestinal side effects.
• Suitable for long-term management of chronic pain.
• Flexible dosing for individual patient needs.
• Improves daily function and comfort.
• Convenient oral administration.

Side Effects

• Indigestion
• Nausea
• Abdominal discomfort
• Headache
• Dizziness
• Fluid retention
• Elevated blood pressure
• Increased risk of cardiovascular events (rare)
• Kidney function impairment (rare)
• Skin rash
• Allergic reactions
• Diarrhea

Safety Measures

• Alcohol - Concurrent alcohol use may increase the risk of gastrointestinal irritation and bleeding. Use sparingly.
• Pregnancy - Avoid during pregnancy, especially in the third trimester, due to potential harm to the fetus.
• Breastfeeding - Not recommended during breastfeeding as the drug may pass into breast milk.
• Liver - Use with caution in patients with hepatic impairment. Regular monitoring of liver function is advised.
• Kidney - Use with caution in patients with renal impairment. Monitor kidney function closely during treatment.
• Lung - Patients with asthma should use with caution, as NSAIDs can sometimes precipitate bronchospasm.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.